News | June 07, 2013

First Patient Treated Worldwide with Accuray's New TomoHDA System

Advanced radiation treatment now available to cancer patients in France

Accuray TomoHD System Centre Oscar Lambret Lille France.

June 7, 2013 — Accuray Incorporated announced the first patient has been treated with its new TomoHDA System at Centre Oscar Lambret in Lille, France. Building upon the proven TomoTherapy Hi-Art and TomoHD technologies, the TomoHDA System is a fully-integrated radiation therapy system designed to treat the full spectrum of cancer patients. Performance enhancements, unrivaled dose distributions and faster treatments are among the multiple new benefits of the TomoHDA System. With the addition of this latest innovation in the TomoTherapy family, Centre Oscar Lambret will be capable of providing excellent care to more patients as a result of the TomoHDA System's increased speed when computing treatment plans and delivering radiation treatment.

"Last month we successfully treated a breast cancer patient with our new TomoHDA. When it comes to cancer care, we are selective in the investments we make and only choose treatments that we believe will make a difference in the quality of care we provide to patients," said Professor Eric Lartigau, M.D., Ph.D., Centre Oscar Lambret. "We are equipping our clinicians with the new TomoHDA technology on top of our two existing TomoTherapy Systems and CyberKnife System, because we believe it is a true innovation that has the potential to optimize cancer care for the full spectrum of cancer patients we treat, especially those battling breast cancer."

Centre Oscar Lambret is a leader in radiation oncology treatment with three TomoTherapy Systems on-site and a CyberKnife System. All three TomoTherapy Systems are equipped with VoLO Technology, offering real-time efficiency for treatment planning and dose calculation. VoLO Technology relies on high-end graphics processing unit (GPU) hardware and software that leverage the GPU's parallel processing abilities to perform dose calculation and optimization in a matter of minutes even for the most complex cases.

"Accuray's significant enhancements to its TomoTherapy and CyberKnife radiation oncology systems have been well-received across Europe with centers in Germany and now France acquiring them in recent months," said Lionel Hadjadjeba, general manager for Europe, India, Middle East, Africa (EIMEA) and senior vice president of International Business at Accuray. "Accuray looks forward to working closely with these centers to ensure patients continue to receive the best possible care."

"Evidenced by Centre Oscar Lambret's adoption of three TomoTherapy Systems and a CyberKnife System, the center clearly recognizes the value Accuray's technologies bring to cancer care," said Joshua H. Levine, president and chief executive officer of Accuray. "Centre Oscar Lambret's decision to invest deeply in Accuray's radiation oncology treatment solutions helps cement its worldwide leadership in cancer treatment and national clinical programs and is in line with their ongoing missions toward care, research and academic teaching and training."

The new TomoHDA System is equipped with the VoLO Technology as well the TomoEDGE Dynamic Jaws technology making it the gold standard for image-guided IMRT (intensity-modulated radiation therapy) treatment, offering faster treatments. The new TomoEDGE technology allows for sharper dose sculpting and reduces treatment time for many patients by approximately half, which will enable clinics to treat more patients per day. Additionally through the use of 3-D daily imaging of the tumor site throughout a patient's course of radiation treatment, physicians often use the information to make important changes to treatment plans ensuring optimal delivery of radiation to only the tumor site, sparing surrounding critical structures and healthy tissue.

For more information: www.centreoscarlambret.fr, www.accuray.com

 

 

Related Content

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Overlay Init